Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia

被引:27
作者
Shibuya, Ayako [1 ]
Itoh, Tomoo [1 ]
Tukey, Robert H. [2 ]
Fujiwara, Ryoichi [1 ]
机构
[1] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan
[2] Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA
来源
SCIENTIFIC REPORTS | 2013年 / 3卷
关键词
HUMAN BILIRUBIN; GLUCURONIDATION; MILK; METABOLISM; UGT1A1; ALPHA; LIVER; MICE; UDP-GLUCURONOSYLTRANSFERASE-1; IDENTIFICATION;
D O I
10.1038/srep02903
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
While breast milk has been known as a cause of neonatal hyperbilirubinemia, the underlying mechanism of breast milk-induced jaundice has not been clarified. Here, the impact of fatty acids on human UDP-glucuronosyltransferase (UGT) 1A1 - the sole enzyme that can metabolize bilirubin - were examined. Oleic acid, linoleic acid, and docosahexaenoic acid (DHA) strongly inhibited UGT1A1 activity. Forty-eight hours after a treatment with a lower concentration of DHA (10 mg/kg), total bilirubin significantly increased in neonatal hUGT1 mice, which are human neonatal jaundice models. In contrast, treatments with higher concentrations of fatty acids (0.1-10 g/kg) resulted in a decrease in serum bilirubin in hUGT1 mice. It was further demonstrated that the treatment with higher concentrations of fatty acids induced UGT1A1, possibly by activation of peroxisome proliferator-activated receptors. Our data indicates that activation of peroxisome proliferator-activated receptors would increase UGT1A1 expression, resulting in reduction of serum bilirubin levels in human infants.
引用
收藏
页数:8
相关论文
共 38 条
  • [1] PROLONGED NEONATAL UNCONJUGATED HYPERBILIRUBINEMIA ASSOCIATED WITH BREAST FEEDING + STEROID PREGNANE-3( ALPHA ) 20) BETA )-DIOL IN MATERNAL MILK THAT INHIBITS GLUCURONIDE FORMATION IN VITRO
    ARIAS, IM
    SEIFTER, S
    GARTNER, LM
    FURMAN, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (11) : 2037 - &
  • [2] ARIAS IRWIN M., 1963, JOUR CLIN INVEST, V42, P913
  • [3] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [4] INHIBITION OF BILIRUBIN CONJUGATION IN RAT-LIVER SLICES BY FREE FATTY-ACIDS, WITH RELEVANCE TO PROBLEM OF BREAST MILK JAUNDICE
    BEVAN, BR
    HOLTON, JB
    [J]. CLINICA CHIMICA ACTA, 1972, 41 (01) : 101 - &
  • [5] BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
  • [6] Dutton GJ., 1980, GLUCURONIDATION DRUG, P69
  • [7] Duval C, 2004, ARCH MAL COEUR VAISS, V97, P665
  • [8] FINLEY DA, 1985, AM J CLIN NUTR, V41, P787
  • [9] The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism
    Fisher, MB
    Paine, MF
    Strelevitz, TJ
    Wrighton, SA
    [J]. DRUG METABOLISM REVIEWS, 2001, 33 (3-4) : 273 - 297
  • [10] Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities
    Fujiwara, Ryoichi
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Katoh, Miki
    Yokoi, Tsuyoshi
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (10) : 1781 - 1787